Akebia Therapeutics (AKBA) Change in Inventory (2019 - 2026)

Akebia Therapeutics (AKBA) has 8 years of Change in Inventory data on file, last reported at $2.5 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $2.5 million, down 48.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.7 million (down 28.38% YoY), and the FY2025 annual result was $23.1 million, down 18.58% from the prior year.
• Change in Inventory eased to $2.5 million in Q1 2026 per AKBA's latest filing, from $17.4 million in the prior quarter.
• Over five years, Change in Inventory peaked at $17.4 million in Q4 2025 and troughed at -$24.5 million in Q4 2022.
• A 5-year average of $2.2 million and a median of $2.5 million in 2026 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory jumped 528.78% in 2024, then sank 1365.87% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$24.5 million in 2022, then soared by 148.18% to $11.8 million in 2023, then decreased by 27.88% to $8.5 million in 2024, then jumped by 105.01% to $17.4 million in 2025, then sank by 85.42% to $2.5 million in 2026.
• Business Quant data shows AKBA's Change in Inventory at $2.5 million in Q1 2026, $17.4 million in Q4 2025, and -$6.9 million in Q3 2025.